The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

Category: Editor’s Choice

Poor gut health connected to severe COVID-19, new review shows
Editor's Choice

Poor gut health connected to severe COVID-19, new review shows

JAN 18, 2021
First Published Clinical Trial Using Live Biotherapeutic Candidate In COVID-19 Patients Suggests Role In Improving Outcomes
Clinical & Manufacturing

First Published Clinical Trial Using Live Biotherapeutic Candidate In COVID-19 Patients Suggests Role In Improving Outcomes

SEP 25, 2020
Seres Therapeutics Announces Positive Topline Results from SER-109 Phase 3 ECOSPOR III Study in Recurrent C. difficile Infection
Clinical & Manufacturing

Seres Therapeutics Announces Positive Topline Results from SER-109 Phase 3 ECOSPOR III Study in Recurrent C. difficile Infection

AUG 10, 2020
The integral role of the microbiome in a post-pandemic world
Editor's Choice

The integral role of the microbiome in a post-pandemic world

AUG 10, 2020
How viruses and bacteria balance each other in the gut microbiome
Editor's Choice

How viruses and bacteria balance each other in the gut microbiome

JUL 22, 2020
Modelling Biology Using Graph Language
Editor's Choice

Modelling Biology Using Graph Language

MAY 12, 2020
Compositional Data Analysis Approaches to Improve Microbiome Studies – From Collection to Conclusions
Editor's Choice

Compositional Data Analysis Approaches to Improve Microbiome Studies – From Collection to Conclusions

MAY 12, 2020
New Statistical Method Identifies Cytokines that Distinguish Stool Microbiomes
Editor's Choice

New Statistical Method Identifies Cytokines that Distinguish Stool Microbiomes

MAY 12, 2020
Rebiotix and Ferring announce world’s first with positive preliminary pivotal Phase 3 data for investigational microbiome-based therapy
Clinical & Manufacturing

Rebiotix and Ferring announce world’s first with positive preliminary pivotal Phase 3 data for investigational microbiome-based therapy

MAY 6, 2020
Microbiome after coronavirus: Investing in the power of microbes
Editor's Choice

Microbiome after coronavirus: Investing in the power of microbes

APR 30, 2020
Until next Probiota, savor the learnings of Probiota Dublin 2020
Editor's Choice

Until next Probiota, savor the learnings of Probiota Dublin 2020

APR 30, 2020